Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0133 | 0.3289 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0133 | 0.3289 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0079 | 0.0938 | 0.5 |
Leishmania major | rac serine-threonine kinase, putative,protein kinase, putative | 0.0248 | 0.8227 | 1 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.0289 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0131 | 0.3192 | 0.9706 |
Brugia malayi | ribosomal protein S6 kinase alpha 3 | 0.0248 | 0.8227 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0133 | 0.3289 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.3192 | 0.2567 |
Giardia lamblia | Kinase, AGC AKT | 0.0248 | 0.8227 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0131 | 0.3192 | 0.9706 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0131 | 0.3192 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.3289 | 0.2672 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0131 | 0.3192 | 0.3879 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0079 | 0.0938 | 0.5 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.0289 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0289 | 1 | 1 |
Onchocerca volvulus | 0.0133 | 0.3289 | 0.5 | |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0133 | 0.3289 | 0.3997 |
Mycobacterium ulcerans | hypothetical protein | 0.0079 | 0.0938 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 490 nM | Inhibitry activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells | ChEMBL. | 12729637 |
IC50 (functional) | = 490 nM | Inhibitry activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells | ChEMBL. | 12729637 |
IC50 (functional) | = 1069 nM | Inhibitry activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells | ChEMBL. | 12729637 |
IC50 (functional) | = 1069 nM | Inhibitry activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells | ChEMBL. | 12729637 |
IC50 (functional) | = 1070 nM | Inhibitory activity of the compound against lipopolysaccharide stimulated TNF-alpha production in THP-1 cells (human monocytic cells) | ChEMBL. | 15837310 |
IC50 (functional) | = 1070 nM | Inhibitory activity of the compound against lipopolysaccharide stimulated TNF-alpha production in THP-1 cells (human monocytic cells) | ChEMBL. | 15837310 |
IC50 (binding) | = 2430 nM | Inhibition of Mitogen-activated protein kinase p38 alpha | ChEMBL. | 15837310 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 12729637 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.